GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.670
-0.100 (-5.65%)
At close: Aug 14, 2026, 4:00 PM EDT
1.697
+0.027 (1.59%)
After-hours: Aug 14, 2026, 7:53 PM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $2.96 million as of August 14, 2026. Its market cap has decreased by -8.89% in one year.
Market Cap
2.96M
Enterprise Value
-7.95M
1-Year Change
-8.89%
Ranking
Category
Stock Price
$1.67
ChartMarket Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $2.96M, a decrease of -88.31%. That is a compound annual growth rate of -47.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 2.96M | 18.39% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
| Apr 24, 2023 | 25.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curis | 3.51M |
| TransCode Therapeutics | 3.47M |
| Galmed Pharmaceuticals | 3.45M |
| Moleculin Biotech | 3.27M |
| HCW Biologics | 3.20M |
| 60 Degrees Pharmaceuticals | 3.18M |
| Jupiter Neurosciences | 3.03M |
| Onconetix | 2.99M |